StockTipsArenaBeta

BUY Max Healthcare Institute Limited — Sahi Research

BUYMax Healthcare Institute Limited
Max Healthcare Institute share price target & all analyst calls

bySahi ResearchHorizon: NA (inferred Swing (≤2wk))18 Sept 2026via Sahi Research Telegram

Entry₹1,042.5Stated
Target₹1,080
Total upside +3.60% (call closed)
Stop loss₹1,018-2.35% risk
Exit₹1,01825 Sept 2026, 12:50 pm
Stop-loss hit-2.35%
Follow Sahi Research for new calls(31% target hit, 131 closed calls)Get alertsWatch MAXHEALTH for new buy/sell callsGet alertsSee 1 active Swing call on MAXHEALTHSee 210 active Swing picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

Frozen at close · 25 Sept 2026
1 supporting6 neutral0 opposing
Supports the BUY call (1)

Max Healthcare Institute Ltd has received communication confirming the allotment of 50,21,212 equity shares in Kalinga Hospital Ltd. This infusion of ~87.87 Crore increases Max Healthcare's shareholdi

BSE · Company Update·7 Sept · 2w ago

(opens in new tab)
Neutral / worth noting (6)

Max Healthcare Seeks Shareholder Nod on RSU Plan, MD Pay and MoA Change via Postal Ballot

NewsGoogle News·19 Sept · 5d ago

(opens in new tab)

Max Healthcare seeks shareholder approval for PLRSU scheme, CMD pay

NewsGoogle News·19 Sept · 5d ago

(opens in new tab)

Max Healthcare Seeks Approval for 73.5 Lakh PRSU Scheme

NewsGoogle News·19 Sept · 5d ago

(opens in new tab)

Max Healthcare MAXHEALTH Postal Ballot 2026: Four Key Resolutions

NewsGoogle News·19 Sept · 5d ago

(opens in new tab)

Max Healthcare (NSE:MAXHEALTH): What Does Its New ESG 'Leader' Rating Mean?

NewsGoogle News·18 Sept · 6d ago

(opens in new tab)
Weighs against the BUY call (0)

Nothing found in this tip’s window yet.

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Max Healthcare Institute

All analyst calls on Max Healthcare Institute

More from Sahi Research

Every call and its outcome